Veterans are spending thousands on retreats in central America where they take ayahuasca, a psychedelic drug one attendant called a “Hail Mary” for PTSD symptoms, according to The New York Times.
The psychedelic brew ayahuasca is being hailed as “a Hail Mary.”
In his keynote speech at Ending Age-Related Diseases 2020, Dr. Aubrey de Grey of SENS Research Foundation discusses the current state of the rejuvenation biotechnology industry in the context of the current pandemic. He mentions the failure of Unity Biotechnology’s Phase 2 clinical trial for osteoarthritis, COVID-19 and the elderly immune system, the current popularization of rejuvenation biotechnology, XPRIZE, and the steps that are currently being taken towards a world without age-related diseases.
HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
LEAF / Lifespan.io is a 501©(3) nonprofit organization. Everything we’ve done thus far and everything we will do in the future is thanks to your support — please stand with us to fight the diseases of aging and increase healthy human lifespan.
► Support us with monthly donations by becoming a Lifespan Hero: https://www.lifespan.io/hero
► Make a one-time donation and learn about other ways to support us here: http://lifespan.io/support
► Learn more, and help us #CrowdsourceTheCure: https://www.lifespan.io
► Subscribe: https://www.youtube.com/user/LifespanIO
JOIN US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Join us, and together, we can overcome diseases like Alzheimer’s, heart disease, and cancer by addressing their shared source: the aging processes themselves.
#Research #Aging #Funding #LEAF #Conference
It was at this webcast that Musk unveiled the latest version of his company NeuraLink’s latest prototype, the Link VO.9 — a chip that would allow humans to control devices with their brains.
Musk said this could eventually help cure people with conditions like memory loss, hearing loss, paralysis, blindness, brain damage, depression and anxiety.
Viewers of the webcast met Gertrude, a pig that had the chip implanted in her brain two months ago. A graph shown onscreen showed the waves inside Gertrude’s brain, which fired when her brain communicated with her snout while she was eating.
Fifty years ago, few scientists believed a drug could fight viruses with low side effects. Then Gertrude Elion showed the doubters “what I could do on my own.”
The evolving understanding of cancer genetics is allowing for clinicians to look at how to move rare cancer treatments, and identifications, forward.
Humans’ natural immune response is at least partly a behavioral response of avoidance. If so, the psychological ramifications of such ingrained behavior could mean trouble for space entrepreneurs.
Seattle healthcare startup KitoTech Medical faced a challenge at the outset of the COVID-19 pandemic. It was difficult to pitch the company’s microMend wound closure device to new hospitals and clinics, limiting the ability to grow its business.
So in response, KitoTech quickly pivoted and developed two new consumer-focused products — and the results have been “remarkable,” according to CEO Ron Berenson.
KitoTech just raised $3 million to help support its growth. The company is known for its microMend device, which was made from technology originally developed at the University of Washington. It uses tiny staples that poke into the skin on either side of a wound and is applied over a cut like a traditional butterfly bandage. The process is painless and can heal wounds up to three times faster than those closed with traditional sutures, according to the company.
FRAMOS, the global partner for Vision Technologies, has developed an industrial grade version of Intel’s® RealSense™ Suite to provide Gigabit Ethernet connectivity and an IP66 rated housing. The D435e industrial 3D GigE Vision camera leverages the advantages of easy-to-integrate 3D vision in rugged environments; enabling real-time positioning, orientation and tracking of robots, automated guided vehicles, and smart machines.
Christopher Scheubel, Product Manager for Intel at FRAMOS, says: “Providing an ethernet solution in combination with Intel’s® RealSense™ Technology is key to enabling 3D vision applications for industry that require longer cable lengths, dust and water resistance, and locked connections. Applications like robotic pick and place systems, automated guided vehicles (AGVs), retail observation, or automatic patient positioning, benefit from the very robust implementation and high usability.”
BACKGROUND
A closed-loop system of insulin delivery (also called an artificial pancreas) may improve glycemic outcomes in children with type 1 diabetes.
METHODS
In a 16-week, multicenter, randomized, open-label, parallel-group trial, we assigned, in a 3:1 ratio, children 6 to 13 years of age who had type 1 diabetes to receive treatment with the use of either a closed-loop system of insulin delivery (closed-loop group) or a sensor-augmented insulin pump (control group). The primary outcome was the percentage of time that the glucose level was in the target range of 70 to 180 mg per deciliter, as measured by continuous glucose monitoring.
RESULTS
The number of reported Covid-19 cases across the globe has surpassed 25 million, with the U.S., Brazil and India leading the grim count, according to data from Johns Hopkins University.
The coronavirus has killed more than 843,000 people worldwide since it emerged from Wuhan, China, late last year, with the Americas reporting the bulk of fatalities. The U.S., Mexico and Brazil represent more than 40% of the global death toll, according to Johns Hopkins.
Reported Covid-19 cases first surpassed 10 million in late June, then reached 20 million just over six weeks later on Aug. 10, according to Johns Hopkins data.
